aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. (2020)

First Author: Fan R
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2020.07.025

PubMed Identifier: 32707225

Publication URI: http://europepmc.org/abstract/MED/32707225

Type: Journal Article/Review

Volume: 73

Parent Publication: Journal of hepatology

Issue: 6

ISSN: 0168-8278